Medifast (MEX:MED) Cyclically Adjusted Revenue per Share: MXN1,387.24 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:MED Medifast Inc MEX:MED
61 GF Score
Price MXN180.00
GF Value MXN121.58
! 4 Warning Signs
View Full Analysis

What is Medifast Cyclically Adjusted Revenue per Share?

Medifast MEX:MED 61 Cyclically Adjusted Revenue per Share is MXN1,387.24 as of Jun. 2026. GuruFocus rates MEX:MED with a GF Score™ of 61/100 and a GF Value™ of MXN121.58. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Medifast's adjusted revenue per share for the three months ended in Jun. 2026 was MXN119.697. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN1,387.24 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Medifast's average Cyclically Adjusted Revenue Growth Rate was 3.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 16.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 19.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Medifast was 35.10% per year. The lowest was 7.80% per year. And the median was 19.80% per year.

As of today (2026-09-01), Medifast's current stock price is MXN180.00. Medifast's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was MXN1,387.24. Medifast's Cyclically Adjusted PS Ratio of today is 0.13.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medifast was 10.96. The lowest was 0.12. And the median was 2.36.


Medifast  (MEX:MED) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Medifast's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=180.00/1387.24
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medifast was 10.96. The lowest was 0.12. And the median was 2.36.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Medifast Cyclically Adjusted Revenue per Share Related Terms


Medifast Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Medifast's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medifast Cyclically Adjusted Revenue per Share Chart

Medifast Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 999.54 1,230.45 1,407.71 1,639.95 2,793.31

Medifast Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,112.38 2,188.09 2,793.31 1,430.64 1,387.24

MEX:MED vs RGS, CLIK, DROR: Cyclically Adjusted Revenue per Share Comparison

For the Personal Services subindustry, Medifast's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medifast Cyclically Adjusted PS Ratio vs Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, Medifast's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medifast's Cyclically Adjusted PS Ratio falls into.


MEX:MED
61GF Score
Medifast Inc MEX:MED
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medifast Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medifast's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=119.697/333.9520*333.9520
=119.697

Current CPI (Jun. 2026) = 333.9520.

Medifast Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 110.980 241.428 153.512
201612 107.207 241.432 148.290
201703 110.729 243.801 151.674
201706 113.543 244.955 154.795
201709 115.843 246.819 156.738
201712 125.957 246.524 170.627
201803 147.562 249.554 197.467
201806 189.367 251.989 250.961
201809 215.298 252.439 284.818
201812 239.036 251.233 317.739
201903 262.881 254.202 345.354
201906 294.160 256.143 383.517
201909 310.997 256.759 404.496
201912 269.389 256.974 350.086
202003 353.903 258.115 457.884
202006 429.578 257.797 556.478
202009 505.781 260.280 648.942
202012 443.572 260.474 568.701
202103 586.114 264.877 738.962
202106 661.724 271.696 813.350
202109 721.275 274.310 878.099
202112 660.662 278.802 791.348
202203 714.456 287.504 829.881
202206 797.565 296.311 898.881
202209 711.181 296.808 800.182
202212 597.884 296.797 672.731
202303 577.156 301.836 638.567
202306 465.129 305.109 509.099
202309 375.796 307.789 407.740
202312 297.217 306.746 323.578
202403 264.648 312.332 282.967
202406 282.344 314.175 300.117
202409 251.559 315.301 266.439
202412 226.140 315.605 239.286
202503 216.257 319.799 225.828
202506 179.703 322.561 186.049
202509 149.225 324.800 153.430
202512 123.002 324.054 126.759
202603 124.594 330.213 126.005
202606 119.697 333.952 119.697

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN1,387.24 mean?
Medifast (MEX:MED) has a Cyclically Adjusted Revenue per Share of MXN1,387.24 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medifast and its competitors.
Is Medifast's Cyclically Adjusted Revenue per Share too high?
Medifast's current Cyclically Adjusted Revenue per Share is MXN1,387.24. Overall, Medifast has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Medifast's Cyclically Adjusted Revenue per Share compare to RGS and CLIK?
Medifast's Cyclically Adjusted Revenue per Share of MXN1,387.24 can be compared against companies in the Personal Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Personal Services company?
A good Cyclically Adjusted Revenue per Share depends on the Personal Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medifast and its competitors. Medifast's current Cyclically Adjusted Revenue per Share is MXN1,387.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medifast stock overvalued right now?
Medifast (MEX:MED) has a current Cyclically Adjusted Revenue per Share of MXN1,387.24. The stock's GF Value™ is MXN121.58, compared to a current price of MXN180.00 — trading 48.1% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN1,387.24. Medifast's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Medifast (MEX:MED), the current Cyclically Adjusted Revenue per Share is MXN1,387.24 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medifast (MEX:MED) Overvalued in 2026?

Based on GuruFocus' analysis, Medifast stock appears to be overvalued. The current stock price of MXN180.00 is trading 48.1% above its estimated GF Value™ of MXN121.58.

Key valuation signals for MEX:MED:

  • Cyclically Adjusted Revenue per Share: MXN1,387.24
  • GF Value™: MXN121.58 vs. price of MXN180.00 (48.1% above fair value)
  • GF Score™: 61/100 with 4 warning signs

No single metric tells the full story. See the MEX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medifast Business Description

Other Exchanges MED:USA0K05:UKMDF:Germany
Address 100 International Drive, Baltimore, MD, USA, 21202
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
61GF Score

Get the complete analysis for MEX:MED

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN180.00
Price
MXN121.58
GF Value